Natick-based ActivSignal receives MassVenture grant
Photo | Google Images
The location of ActivSignal's headquarters in Natick
A Natick company that has helped detect levels of COVID-19 in wastewater testing has been named a recipient of a $100,000 award from venture capital firm MassVentures.
ActivSignal, which was founded in 2016 by Malcolm MacKenzie and Ilya Alexandrov, received the award for its multiplex paired-antibody amplified detection device, which is able to analyze the activity of multiple cell signaling pathways. The device was used in the Canadian province of Ottawa in collaboration with the University of Ottawa to track COVID-19 by measuring viral proteins in wastewater, according to the company's website.
The award given to ActivSignal is through MassVentures’ START Program, which provides non-dilutive grant funding to Massachusetts-based startups to help them convert research developed under federal Small Business Innovation Research and Small Business Tech Transfer research contracts into businesses and jobs. ActivSignal was one of 10 new companies to receive the firm’s Stage 1 award, and the only one located in the MetroWest area.
With the winning of the award, ActivSignal is eligible to potentially receive a Stage 2 award, for $200,000, from MassVentures in the upcoming year. Five Stage 1 winners are selected each year for the Stage 2 award.
The award was given out for the 11th annual START awards by MassVentures. The firm has awarded a total of $31.2 million to 105 companies that have gone on to raise more than $4 billion and employ more than 2,500 people in Massachusetts, since 2012.
WBJ Web Partners
Most Recent
Most Recent
0 Comments